Jianmin Group (600976): Continued to provide performance growth based on the pediatric brand single product Tibeiuhuang
Jianmin Group (600976): Performance is in line with expectations, sports training, Niu Huang's performance is outstanding
Jianmin Group (600976) Annual Report Review Report: Performance growth is in line with expectations, the growth rate of Longmuzhuang bone pellets is impressive
Jianmin Group (600976) 2023 Annual Report Review: Performance Growth Meets Expectations
Jianmin Group (600976): The gross margin of the main business increased steadily, and Jianmin Dapeng's profit continued to grow
Jianmin Group (600976): Second-tier product, cultivating beef yolk in vitro with high elastomer, is growing steadily
Jianmin Group (600976): OTC increases brand creation and gradual introduction of new prescription products
Jianmin Group (600976): The performance is in line with expectations and the profit level is stable
Jianmin Group (600976) Report Review for the Third Quarter of 2023: Sports Training, Niuhuang Continues to Contribute to Steady Performance Growth
Jianmin Group (600976) Third Quarterly Review Report: Strong physical training performance in the third quarter and steady overall growth
Jianmin Group (600976): Steady growth in performance, the pharmaceutical industry and investment income continue to contribute to profits
Jianmin Group (600976): The main business is growing rapidly, and Dapeng has performed well
Jianmin Group (600976) 2023 semi-annual report review: The pharmaceutical industry sector and Jianmin Dapeng contributed a high growth rate, and the net profit performance was impressive
Jianmin Group (600976): Industry+investment income drives profit growth, impressive results in a single quarter
Jianmin Group (600976): Leading varieties lead industrial growth and achieve outstanding performance on the profit side
Jianmin Group (600976) 2023 Interim Report: OTC Brand Releases Physical Training Niuhuang Delivery Returns to Normal
Jianmin Group (600976) Semi-Annual Report Review: Profit Growth Meets Expectations R&D Helps Long-term Development
Review of the 2023 semi-annual report of Jianmin Group (600976): Large products continue to drive performance growth beyond expectations
Jianmin Group (600976): The main business continues to recover, and the investment income performance is impressive
Jianmin Group (600976): Based on a century-old Chinese brand, the Q1 performance is in line with market expectations
No Data